New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
08:13 EDTMRShort reports on Mindray Medical create buying opportunity, says Oppenheimer
Oppenheimer believes that Mindray's fundamentals are improving, and it expects the company's profits to rise 10.9% in FY14. The firm keeps an Outperform rating on the shares.
News For MR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
08:07 EDTMRMindray Medical to acquire remaining stake in Wuhan Dragonbio
Subscribe for More Information
June 24, 2015
08:07 EDTMRMindray Medical forms special committee to evaluate 'going private' proposal
Mindray Medical announced that its board has formed a special committee comprised of three independent directors of the company, Ronald Ede, Kern Lim and Qiyao Wu, to consider the previously announced non-binding proposal received by the company's board on June 4, 2015 from Li Xiting, its Executive Chairman of the Board, President and Co-Chief Executive Officer, Xu Hang, its Chairman of the Board, and Cheng Minghe, its Co-Chief Executive Officer and Chief Strategic Officer. The Special Committee has retained Lazard Asia Limited as its independent financial advisor and Shearman & Sterling as its U.S. legal counsel to assist it in its evaluation of the Proposed Transaction and any other alternative transaction.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use